IRIS UniCatt

Leone, Giuseppe
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 11.774
NA - Nord America 11.735
AS - Asia 7.059
SA - Sud America 1.264
AF - Africa 181
OC - Oceania 181
Continente sconosciuto - Info sul continente non disponibili 12
Totale 32.206
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.451
DE - Germania 5.192
SG - Singapore 2.921
CN - Cina 2.656
SE - Svezia 1.597
UA - Ucraina 1.084
BR - Brasile 1.052
IT - Italia 884
FR - Francia 619
GB - Regno Unito 604
PL - Polonia 485
IE - Irlanda 385
IN - India 303
FI - Finlandia 259
ID - Indonesia 240
VN - Vietnam 237
RU - Federazione Russa 185
TR - Turchia 185
AU - Australia 156
CA - Canada 152
NL - Olanda 89
AR - Argentina 84
MX - Messico 81
JP - Giappone 80
ES - Italia 64
BD - Bangladesh 61
IQ - Iraq 53
CI - Costa d'Avorio 51
HK - Hong Kong 50
BE - Belgio 49
ZA - Sudafrica 38
IR - Iran 31
AT - Austria 29
CH - Svizzera 29
EC - Ecuador 28
NO - Norvegia 28
VE - Venezuela 26
NZ - Nuova Zelanda 25
KR - Corea 24
CO - Colombia 22
RO - Romania 22
EG - Egitto 21
IL - Israele 21
AE - Emirati Arabi Uniti 20
UZ - Uzbekistan 20
PK - Pakistan 19
LT - Lituania 18
PY - Paraguay 18
BG - Bulgaria 17
SA - Arabia Saudita 17
GR - Grecia 16
JO - Giordania 16
HU - Ungheria 15
MA - Marocco 14
PT - Portogallo 14
CL - Cile 13
CZ - Repubblica Ceca 13
DZ - Algeria 12
KE - Kenya 12
SK - Slovacchia (Repubblica Slovacca) 11
NP - Nepal 10
AZ - Azerbaigian 9
HR - Croazia 9
JM - Giamaica 9
LV - Lettonia 9
PE - Perù 9
CR - Costa Rica 8
DO - Repubblica Dominicana 7
EU - Europa 7
GE - Georgia 7
KZ - Kazakistan 7
MY - Malesia 7
RS - Serbia 7
TH - Thailandia 7
UY - Uruguay 7
DK - Danimarca 6
ET - Etiopia 6
LB - Libano 6
PH - Filippine 6
TN - Tunisia 6
BA - Bosnia-Erzegovina 5
BO - Bolivia 5
LK - Sri Lanka 5
LU - Lussemburgo 5
MK - Macedonia 5
OM - Oman 5
TW - Taiwan 5
AL - Albania 4
AM - Armenia 4
BZ - Belize 4
HN - Honduras 4
KG - Kirghizistan 4
NI - Nicaragua 4
PS - Palestinian Territory 4
SN - Senegal 4
XK - ???statistics.table.value.countryCode.XK??? 4
BB - Barbados 3
BH - Bahrain 3
BY - Bielorussia 3
EE - Estonia 3
Totale 32.150
Salva come PNG Salva come JPEG
Città #
Chandler 1.602
Singapore 1.331
Ashburn 991
Jacksonville 695
Beijing 471
Nanjing 453
San Mateo 450
Dearborn 445
Warsaw 437
Dublin 371
Ann Arbor 348
Nürnberg 329
Houston 298
Woodbridge 278
Los Angeles 269
Wilmington 256
New York 238
Jakarta 213
Milan 210
Munich 208
Seattle 205
Hangzhou 183
Hefei 182
Nanchang 181
Redwood City 153
Lawrence 149
Boston 144
Fairfield 135
Izmir 135
Bremen 130
Marseille 120
Buffalo 119
Dallas 114
Moscow 111
Kunming 100
Lancaster 98
Frankfurt am Main 97
São Paulo 90
Chicago 86
Cattolica 84
Rome 83
Shenyang 80
Hanoi 76
Zhengzhou 74
Ho Chi Minh City 68
University Park 67
Tianjin 64
Guangzhou 62
Hebei 61
Leawood 59
Princeton 58
Mountain View 55
Boardman 52
Abidjan 51
London 51
Redmond 51
Changsha 50
Hong Kong 47
Auburn Hills 46
Jiaxing 46
Norwalk 46
Cambridge 44
Shanghai 44
Tokyo 44
Brussels 43
Philadelphia 43
Kent 39
Pune 39
San Francisco 39
Toronto 39
Brooklyn 38
Santa Clara 37
Sydney 37
Jinan 35
Fremont 34
Düsseldorf 32
Helsinki 32
Phoenix 32
Atlanta 31
Augusta 30
Rio de Janeiro 28
Detroit 27
Melbourne 27
Portland 26
San Jose 26
Belo Horizonte 25
San Diego 25
Simi Valley 23
Adelaide 22
Amsterdam 22
Brisbane 22
Denver 22
Lanzhou 22
Porto Alegre 22
Changchun 21
Stockholm 21
Turku 20
Chatsworth 19
Baghdad 18
Dhaka 18
Totale 14.924
Salva come PNG Salva come JPEG
Nome #
VITAMIN B12 DEFICIENCY: CORRELATION BETWEEN MTHFR POLYMORPHISMS AND CLINICAL AND LABORATORY FINDINGS 2.876
Incidence of acute myeloid leukemia after breast cancer 362
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 337
Factors associated with mortality in bacteremic patients with haematologic malignancies 337
Fanconi anemia gene variants in therapy-related myeloid neoplasms 300
THE PROGNOSTIC ROLE OF EBV IN PERIPHERAL BLOOD OF PATIENTS WITH DIFFUSE LARGE B CELL LYMPHOMA 271
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 270
Quantification of DAPK1 Promoter Methylation in Bone Marrow and Peripheral Blood as a Follicular Lymphoma Biomarker 260
Therapy-related leukemias and myelodysplasia : susceptibility and incidence. 253
Association of congenital protein C deficiency and latent myeloproliferative disease as cause of splanchnic venous thrombosis in a 34-year-old woman 247
A Novel Route of Transplantation of Human Cord Blood Stem Cells in Preimmune Fetal Sheep: The Intracelomic Cavity 244
Mutational analysis of bone marrow mesenchymal stromal cells in myeloid malignancies 241
A) A human umbilical cord stem cell rescue therapy in a murine model of toxic liver injury. 219
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma. 215
Improvement of mortality rate and decrease in histologic hepatic injury after human cord blood stem cell infusion in a murine model of hepatotoxicity. 214
PTEN/PI3K/AKT PATHWAY DYSREGULATION IN MYELODYSPLASTIC GRANULOCYTES 214
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 213
GSK3β down-regulation in Mesenchymal Stem Cells from patients with Myelodysplastic Syndrome. 208
MUTATIONAL ANALYSIS OF BONE MARROW MESENCHIMAL STROMAL CELLS IN MYELOID MALIGNANCIES 207
Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. 204
-Improvement of mortality rate and decrease in histologic hepatic injury after human cord blood stem cell infusion in a murine model of hepatotoxicity 201
Anemia in Diffuse Large B cell Non-Hodgkin Lymphoma: The Role of IL-6, Hepcidin and Erythropoietin 200
CD68+ cell count, early evaluation with PET and plasma TARC levels predict response in Hodgkin lymphoma 198
Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin 197
Systemic granulomatous reaction secondary to treatment of bladder cancer with Bacillus Calmette-Guerin 197
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 191
DEREGULATION OF PI3K/AKT SIGNALING IN BONE MARROW MESENCHIMAL STROMAL CELLS FROM PATIENTS WITH DE NOVO AND THERAPY-RELATED ACUTE MYELOID LEUKEMIA 190
Von hippel-lindau disease and erythrocytosis 188
Gemtuzumab ozogamicin, citosine arabinoside, G-CSF combination (G-AraMy) in the treatment of elderly patients with poor-prognosis acute myeloid leukemia. 185
Correlation between paraproteinaemia and viral reactivation after allo-SCT 182
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: safety and efficacy evaluation 180
in Higher-Risk Myelodysplastic Syndromes and Low Blast Count Acute Myeloid Leukemia: Results of the BMT-AZA Prospective Study 179
Serum of healthy donors receiving granulocyte colony-stimulating factor induces T cell unresponsiveness 176
Human cordonal stem cell intraperitoneal injection can represent a rescue therapy after an acute hepatic damage in immunocompetent rats. 176
Revised International Prognostic Scoring System (IPSS) predicts survival and leukemic evolution of myelodysplastic syndromes significantly better than IPSS and WHO Prognostic Scoring System: validation by the Gruppo Romano Mielodisplasie Italian Regional Database 176
Safety and efficacy profile of G-CSF therapy in patients with acute on chronic liver failure 175
The intracoelomic route: a new approach for in utero human cord blood stem cell transplantation. 174
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 173
Effect of intensive vs standard statin therapy on endothelial progenitor cells and left ventricular function in patients with acute myocardial infarction: Statins for regeneration after acute myocardial infarction and PCI (STRAP) trial 173
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 173
Why methylation is not a marker predictive of response to hypomethylating agents 170
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 168
The viral load of Epstein-Barr virus (EBV) DNA in peripheral blood predicts for biological and clinical characteristics in Hodgkin lymphoma 167
Reduced BRCA1 expression due to promoter hypermethylation in therapy-related acute myeloid leukaemia 167
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 167
Characterization of anti-D monoclonal antibody reagents based on their reactivity with the weak D phenotype 166
-No evidence of hematopoietic stem cell mobilization in patients submitted to hepatectomy or in patients with acute on chronic liver failure 166
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas. 164
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 164
Different STAT-3 and STAT-5 phosphorylation discriminates among Ph-negative chronic myeloproliferative diseases and is independent of the V617F JAK-2 mutation. 164
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 164
Impairment of PI3K/AKT and WNT/β-catenin pathways in bone marrow mesenchymal stem cells isolated from patients with myelodysplastic syndromes 162
-How does human stem cell therapy influence gene expression after liver injury? Microarray evaluation on a rat model 161
-Human cordonal stem cell intraperitoneal injection can represent a rescue therapy after an acute hepatic damage in immunocompetent rats 161
Response to 5-azacytidine in a patient with relapsed Hodgkin Lymphoma and a therapy-related myelodysplastic syndrome 161
Analysis of genome-wide methylation and gene expression induced by 5-aza-2'-deoxycytidine identifies BCL2L10 as a frequent methylation target in acute myeloid leukemia. 161
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 161
T lymphocyte subsets and platelet-associated IgG in idiopathic thrombocytopenic purpura: effect of splenectomy. 160
Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma 160
Prospective evaluation of Epstein-Barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 160
Mutations of epigenetic regulators and of the spliceosome machinery in therapy-related myeloid neoplasms and in acute leukemias evolved from chronic myeloproliferative diseases 160
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 159
Impaired bactericidal and fungicidal activities of neutrophils in patients with myelodysplastic syndrome 158
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 158
SETBP1 mutations in 106 patients with therapy-related myeloid neoplasms. 158
In vitro cardiomyocyte differentiation of umbilical cord blood cells: crucial role for c-kit(+) cells 158
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 158
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 156
Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma. 156
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia 154
Usefulness of granulocyte colony-stimulating factor in patients with a large anterior wall acute myocardial infarction to prevent left ventricular remodeling (the rigenera study). 154
Epigenetic changes in therapy-related MDS/AML 153
A human umbilical cord stem cell rescue therapy in a murine model of toxic liver injury. 152
Gene expression profiling of myelodysplastic CD34+ hematopoietic stem cells treated in vitro with decitabine 152
Antithrombin III in full-term and pre-term newborn infants: three cases of neonatal diagnosis of AT III congenital defect 151
Gene profiling of bone marrow- and adipose tissue-derived stromal cells: a key role of Kruppel-like factor 4 in cell fate regulation 151
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: Safety and efficacy evaluation. 151
New and old monoclonal antibodies for the treatment of chronic lymphocytic leukemia 150
Non-invasive detection of fetal Rhesus D Status: A comparison between Polymerase Chain Reaction and flow Cytometry 150
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 150
Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function 150
Similarities and differences between therapy-related and elderly acute myeloid leukemia 149
Incidence and clinical impact of extended-spectrum-beta-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies 148
Recurrent thrombosis in patients with polycythemia vera and essential thrombocythemia: incidence, risk factors, and effect of treatments 147
Role of (18)F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients 147
The use of low-dose alemtuzumab in pretreated B-cell chronic lymphocytic leukemia. Leukemia. 146
Polymorphisms of detoxification and DNA repair enzymes in myelodyplastic syndromes 144
Whole blood EBV-DNA predicts outcome in diffuse large B-cell lymphoma 144
Primary plasma cell leukemia followed by testicular plasmacytoma 143
Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms 143
Role of 18F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients. 143
All-trans retinoic acid in association with low dose cytosine arabinoside in the treatment of acute myeoid leukemia in elderly patients 143
Invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. 142
Adherence to international guidelines for the treatment of invasive aspergillosis in acute myeloid leukaemia: feasibility and utility (SEIFEM-2008B study). 141
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 140
Interleukin-6 plasma levels are modulated by a polymorphism in the NF-κB1 gene and are associated with outcome following rituximab-combined chemotherapy in diffuse large B-cell non-Hodgkin lymphoma 140
Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas 140
EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS 140
Atypical presentation of progressive multifocal leukoencephalopathy in a multiple myeloma patient after auto SCTsuccessfully treated with combination treatment. 139
Hereditary thrombocytosis caused by MPLSer505Asn is associated with a high thrombotic risk, splenomegaly and progression to bone marrow fibrosis 139
Totale 20.607
Salva come PNG Salva come JPEG
Categoria #
all - tutte 108.498
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.498
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.637 0 0 0 0 0 213 324 58 285 162 529 66
2021/20222.089 219 244 35 105 138 77 54 347 86 137 283 364
2022/20234.360 520 639 331 722 311 530 223 346 508 46 118 66
2023/20242.556 104 569 88 110 149 386 124 104 102 179 356 285
2024/20254.327 322 248 396 178 442 120 147 211 674 338 666 585
2025/20264.982 1.460 329 549 876 1.672 96 0 0 0 0 0 0
Totale 32.339